Hemianopsia Market

Hemianopsia Market Analysis by Homonymous Hemianopsia, Quadrantanopsia, and Bitemporal Hemianopsia from 2023 to 2033

Analysis of Hemianopsia Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Hemianopsia Market Outlook (2023 to 2033)

The global hemianopsia market is valued at US$ 333.9 million in 2023 and is projected to reach US$ 720.9 million by 2033. Global demand for hemianopsia treatment solutions is forecasted to increase rapidly at a CAGR of 8% between 2023 and 2033.

Hemianopsia, also known as hemianopia or hemiopia, is a condition where an individual loses half of their visual field in one or both eyes due to damage in the brain's visual processing areas. This condition can be caused due to various conditions, including stroke, traumatic brain injuries, brain tumours, and other neurological disorders.

  • Around 2 billion people worldwide are living with some kind of vision disorder, according to WHO.

Hemianopsia is triggered by the central nervous system's disturbance of visual pathways. The rising prevalence of stroke and neurological disorders worldwide is boosting the demand for hemianopsia treatment solutions.

  • According to the Global Stroke Factsheet published by the World Health Organization (WHO) in 2022, the lifetime risk of having a stroke has increased by fifty percent over the past 17 years, with an estimated 1 in 4 people experiencing a stroke.

Lesions can be categorised as prechiasmal, chiasmal, or retrochiasmal. Monocular blindness is brought on by prechiasmal lesions, which damage the optic nerve of the affected eye. Bitemporal hemianopsia is caused by optic chiasm lesions that impair the medial decussating nasal fibers. Optic radiations, the primary visual cortex, and the optic tract can all be affected by lesions posterior to the chiasm.

Homonymous hemianopsia is typically caused by injury to the optic tract and primary visual cortex, whereas damage to the optic radiations causes an inferior or superior quadrantanopia. Homonymous hemianopsia can be further classified into right homonymous hemianopsia and left homonymous hemianopsia.

Macular sparing, also known as homologous hemianopsia with preservation of the central visual field, is a sign that the main visual cortex, which receives a dual circulatory supply from the middle and posterior cerebral arteries, has been damaged.

Technologies referred to as ‘assistive’ are those that aim to make it easier for persons with vision disabilities and other challenges to live a comfortable and normal life. Due to an increase in trauma cases and traffic accidents, the number of people with disabilities has been rising quickly in recent years. Future sales of assistive devices for the visually impaired are expected to be greatly influenced by the increasing prevalence of vision impairment and blindness worldwide.

Report Attributes Details
Hemianopsia Market Size (2023E) US$ 333.9 Million
Forecasted Market Value (2033F) US$ 720.9 Million
Global Market Growth Rate (2023 to 2033) 8% CAGR
Leading Regional Market North America
Key Companies Profiled Vycor Medical, Inc.; RetroSense Therapeutics, LLC; Chadwick Optical; Healio; Carl Zeiss AG,; AbbVie Inc; Aerie Pharmaceuticals, Inc.; Novartis AG; AkzoNobel N.V.; F. Hoffmann-La Roche Ltd.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

What is Driving the Hemianopsia Treatment Market Forward?

“Hemianopsia - Untapped Market Ripe for Innovation and Disruption”

The hemianopsia market presents both opportunities and challenges for newcomers. On the one hand, there is a significant unmet need for effective treatments for this condition, which affects a large and growing patient population. As awareness of the condition increases, demand for treatments is likely to rise, creating a potentially lucrative market for new entrants.

However, there are also significant barriers to entry in this field. The high costs associated with developing and marketing advanced treatment solutions, as well as the need to navigate complex regulatory frameworks, can make it difficult for newcomers to establish a foothold.

There are several established market players, including pharmaceutical companies, medical device manufacturers, and others. These companies have significant resources and expertise in the field, making it challenging for newcomers to compete effectively.

To succeed in this field, new entrants will need to develop innovative, cost-effective treatments that address the unmet needs of patients and differentiate themselves from existing players. They will also need to build strong partnerships with healthcare providers and payers, as well as invest in robust marketing and educational campaigns to increase awareness of their products and services.

Overall, while the hemianopsia market offers significant opportunities for newcomers, it is a highly competitive and complex field that requires careful planning and execution to succeed.

“Culprits Behind Hemianopsia - Stroke, Head Injury, and More”

A stroke, a head injury, a mass occupying lesion, invasive surgery, or a neurologic disorder such as multiple sclerosis, Alzheimer's disease, or epilepsy can all cause homologous hemianopsia. Pituitary adenomas, craniopharyngiomas, and meningiomas are among the mass-occupying lesions that are commonly linked to bitemporal hemianopsia.

Bitemporal hemianopsia can also be brought on by vascular diseases such as anterior communicating artery aneurysms or basilar skull trauma. Thus, increasing cases of all such disorders creates a high risk of hemianopsia, which further is likely to boost the sales of hemianopsia treatment solutions during the forecast period.

Hemianopsia is a visual field defect that occurs as a result of stroke, specifically damage to the brain's visual processing areas. A stroke, which is a disruption of blood flow to the brain, can occur due to either an ischemic stroke, where a blood vessel becomes blocked and restricts blood flow, or a hemorrhagic stroke, where bleeding occurs in the brain.

  • According to the Centers for Disease Control & Prevention, every 40 seconds one in the United States experiences a stroke.
  • Globally, traumatic brain injury (TBI) is a leading cause of health problems and visual disability. According to studies by "uptodate," estimates of the annual incidence of TBI range from 27 to 69 million worldwide.
  • According to a WHO report published in September 2022, over 55 million people worldwide suffer from dementia, with almost 10 million new cases being diagnosed each year. Alzheimer's condition is the most widespread type of dementia, accounting for 60% to 70% of the total number of cases of dementia, according to the WHO.
  • According to the study ‘Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition’, which was released in December 2020. There are around 2.8 million cases of multiple sclerosis (MS) globally.
  • Epilepsy is one of the most prevalent neurological diseases worldwide, with an estimated 50 million people suffering from it, according to the World Health Organization's February 2022 update.

“Hemianopsia Awareness on the Rise - Impact of Advanced Diagnostics on Public Health”

Development of advanced diagnostic technologies such as OCT (Optical Coherence Tomography), MRI (Magnetic Resonance Imaging), and CT (Computed Tomography) has greatly improved the diagnosis of hemianopsia. This has led to greater awareness and earlier detection of the condition, thereby boosting the growth of the market for hemianopsia.

“Virtual Reality, Prism Adaptation, and Visual Prostheses - Key Players Driving Hemianopsia Treatment to Next Level”

Key players in the hemianopsia market are taking major efforts on developing new technologies and treatment options for hemianopsia, such as virtual reality-based rehabilitation, prism adaptation therapy, and visual prostheses. These advancements are expected to generate potential opportunities in the hemianopsia market by increasing the availability of effective treatments.

“Small Incisions, Big Results Due to Minimally-Invasive Hemianopsia Treatment”

There is a growing preference for minimally-invasive treatment options, such as visual field restoration therapy, which has minimal side effects and faster recovery time compared to invasive surgeries. This is expected to drive the demand for non-invasive treatments for hemianopsia

Which Aspects Should Manufacturers of Hemianopsia Treatment Solutions Focus More On?

“Delayed Treatment and Poorer Outcomes Resulting from Misdiagnosis”

One of the key challenges is limited awareness and understanding of the condition among patients and healthcare professionals in some regions. Hemianopsia is not well-known and often goes undiagnosed or misdiagnosed, which can lead to delayed treatment and poorer outcomes for patients.

In addition, there is often a lack of awareness of the available treatment options, which can limit access for patients.

Limited availability of specialized treatment centers and healthcare professionals with expertise in hemianopsia in developing or poor regions further hampers sales of hemianopsia treatment solutions.

“High Overall Treatment Costs”

Another challenge is the high costs associated with diagnosis and treatment. Diagnostic tests such as MRI or CT scans can be expensive, and specialized treatment options such as visual field restoration therapy or visual prostheses may not be covered by insurance. This can make it difficult for some patients to access the care they need.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Country-wise Analysis

What is Influencing the Sales of Hemianopsia Treatment Solutions in the United States?

“Advanced Healthcare Facilities and Point-of-Care Services Driving Hemianopsia Treatment Solution Sales”

Advanced healthcare facilities, well-equipped hospitals, rising cases of strokes, and availability of point-of-care services are responsible for the maximum sales of hemianopsia treatment solutions in the United States. The significant demand for hemianopsia products is caused by a large patient population and ease of accessing advanced treatment.

  • More than 795,000 Americans experienced strokes in 2021, according to data released by the Centers for Disease Control and Prevention (CDC) in April 2022.

What is the Demand Outlook for Hemianopsia Treatment in Japan?

“Supportive Healthcare Initiatives Catalyst for Hemianopsia Treatment Technology Sales Growth”

Japan is a highly profitable marketplace for producers of hemianopsia technologies, as more than 30% of Japan’s population is 60 or older. There is a high prevalence rate of eye disorders among the older population. In Japan, demand for advanced hemianopsia treatment options such as low-vision assistive devices and visual prostheses is expected to expand over the next 10 years as the country's ageing population grows.

During the next ten years, it is anticipated that the introduction of supportive government healthcare initiatives to enhance the quality of life for the elderly in Japan would have a significant influence on the sales of hemianopsia treatment technologies.

How is Demand for Hemianopsia Treatment Technologies Progressing in Germany?

“Germany's High Rate of Head Injuries & Skull Fractures Increasing Risk of Hemianopsia”

Germany is one of the leading marketplaces in the European region. This may be due to the presence of key market players and well-established healthcare facilities.

There is also a high rate of the elderly population and a prevalence of brain illnesses such as brain tumours, epilepsy, and stroke in the country. Therefore, each of these elements plays a big part in the growing demand for neurological monitoring equipment. Thus, the rising incidence of traumatic brain injuries increases the danger of hemianopsia, which further boosts demand for hemianopsia treatment devices.

  • In April 2021, a paper in the journal Safety Science revealed that Germany has a high rate of head injuries and skull fractures.

Category-wise Analysis

Why Do Hospitals Account for High Sales of Hemianopsia Treatment Solutions?

“Advanced Technologies & Skilled Workforce Attract Target Patients”

Hospitals are playing a crucial role in boosting the sales of hemianopsia treatment solutions. With the rising prevalence of stroke and other neurological disorders, there has been a significant surge in the demand for hemianopsia treatment devices and solutions. Hospitals, being the primary centers for the diagnosis and treatment of these conditions, are preferred as the first choice for treatment procedures by target patients.

Hospitals are investing heavily in the latest technologies and equipment to provide advanced treatment to their patients. They are adopting low-vision assistive devices, visual prostheses, and several other treatment devices. This has led to a significant increase in the sales of hemianopsia treatment devices and solutions.

In addition to providing advanced treatment, hospitals are also conducting awareness programs and educational campaigns to create awareness about hemianopsia and its treatment options.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Competitive Landscape

Leading companies in the hemianopsia market are investing heavily in research and development activities to come up with innovative and advanced hemianopsia treatment solutions. This gives them an edge in the market and boosts their revenue growth. They are also entering into partnerships and collaborations with hospitals, clinics, and other healthcare providers to increase their reach and boost sales.

Key Segments of Hemianopsia Industry Research

  • By Type :

    • Homonymous Hemianopsia
    • Quadrantanopsia
    • Bitemporal Hemianopsia
  • By Treatment :

    • Vision Restoration Therapy
    • Visual Field Expander Aid
  • By End User :

    • Hospitals
    • Speciality Clinics
  • By Region :

    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia & Oceania
    • MEA

Table of Content

  • 1. Global Market - Executive Summary
  • 2. Global Market Overview
  • 3. Market Risks and Trends Assessment
  • 4. Market Background and Foundation Data Points
  • 5. Global Market Demand (US$ Mn) Analysis 2018 to 2022 and Forecast, 2023 to 2033
  • 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
    • 6.1. Homonymous Hemianopsia
    • 6.2. Quadrantanopsia
    • 6.3. Bitemporal Hemianopsia
  • 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Treatment
    • 7.1. Vision Restoration Therapy
    • 7.2. Visual Field Expander Aid
  • 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by End User
    • 8.1. Hospitals
    • 8.2. Specialty Clinics
  • 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region
    • 9.1. North America
    • 9.2. Latin America
    • 9.3. Europe
    • 9.4. East Asia
    • 9.5. South Asia & Oceania
    • 9.6. Middle East and Africa (MEA)
  • 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
  • 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
  • 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
  • 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
  • 14. South Asia & Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033
  • 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
  • 16. Market Structure Analysis
  • 17. Competition Analysis
    • 17.1. Vycor Medical, Inc.
    • 17.2. RetroSense Therapeutics, LLC
    • 17.3. Chadwick Optical
    • 17.4. Healio
    • 17.5. Carl Zeiss AG
    • 17.6. AbbVie Inc
    • 17.7. Aerie Pharmaceuticals, Inc.
    • 17.8. Novartis AG
    • 17.9. AkzoNobel N.V.
    • 17.10. F. Hoffmann-La Roche Ltd.
  • 18. Assumptions and Acronyms Used
  • 19. Research Methodology

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 01: Global Market Value (US$ Mn) Analysis, by Type, 2018 to 2022

Table 02: Global Market Value (US$ Mn) Analysis, by Type, 2023 to 2033

Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033

Table 04: Global Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022

Table 05: Global Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033

Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033

Table 07: Global Market Value (US$ Mn) Analysis, by End User, 2018 to 2022

Table 08: Global Market Value (US$ Mn) Analysis, by End User, 2023 to 2033

Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033

Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2022

Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2023 to 2033

Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2023 to 2033

Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 16: North America Market Value (US$ Mn) Analysis, by Type, 2018 to 2022

Table 17: North America Market Value (US$ Mn) Analysis, by Type, 2023 to 2033

Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033

Table 19: North America Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022

Table 20: North America Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033

Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033

Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2018 to 2022

Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2023 to 2033

Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033

Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 28: Latin America Market Value (US$ Mn) Analysis, by Type, 2018 to 2022

Table 29: Latin America Market Value (US$ Mn) Analysis, by Type, 2023 to 2033

Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033

Table 31: Latin America Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022

Table 32: Latin America Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033

Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033

Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2018 to 2022

Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2023 to 2033

Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033

Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 40: Europe Market Value (US$ Mn) Analysis, by Type, 2018 to 2022

Table 41: Europe Market Value (US$ Mn) Analysis, by Type, 2023 to 2033

Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033

Table 43: Europe Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022

Table 44: Europe Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033

Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033

Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2018 to 2022

Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2023 to 2033

Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033

Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 52: East Asia Market Value (US$ Mn) Analysis, by Type, 2018 to 2022

Table 53: East Asia Market Value (US$ Mn) Analysis, by Type, 2023 to 2033

Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033

Table 55: East Asia Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022

Table 56: East Asia Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033

Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033

Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2018 to 2022

Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2023 to 2033

Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033

Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Type, 2018 to 2022

Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Type, 2023 to 2033

Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033

Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022

Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033

Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033

Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2018 to 2022

Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2023 to 2033

Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033

Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 76: MEA Market Value (US$ Mn) Analysis, by Type, 2018 to 2022

Table 77: MEA Market Value (US$ Mn) Analysis, by Type, 2023 to 2033

Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033

Table 79: MEA Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022

Table 80: MEA Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033

Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033

Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2018 to 2022

Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2023 to 2033

Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2018 to 2022

Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033

Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2033

Figure 04: Global Market Incremental $ Opportunity, 2023 to 2033

Figure 05: Global Market Share and BPS Analysis by Type, 2023 & 2033

Figure 06: Global Market Y-o-Y Growth Projections by Type, 2023 to 2033

Figure 07: Global Market Attractiveness Analysis by Type, 2023 to 2033

Figure 08: Global Market Share and BPS Analysis by Treatment, 2023 & 2033

Figure 09: Global Market Y-o-Y Growth Projections by Treatment, 2023 to 2033

Figure 10: Global Market Attractiveness Analysis by Treatment, 2023 to 2033

Figure 11: Global Market Share and BPS Analysis by End User, 2023 & 2033

Figure 12: Global Market Y-o-Y Growth Projections by End User, 2023 to 2033

Figure 13: Global Market Attractiveness Analysis by End User, 2023 to 2033

Figure 14: Global Market Share and BPS Analysis by Region, 2023 & 2033

Figure 15: Global Market Y-o-Y Growth Projections by Region, 2023 to 2033

Figure 16: Global Market Attractiveness Analysis by Region, 2023 to 2033

Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018 to 2022

Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033

Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2033

Figure 20: North America Market Incremental $ Opportunity, 2023 to 2033

Figure 21: North America Market Share Analysis by Country, 2023 & 2033

Figure 22: North America Market Y-o-Y Growth Projection by Country, 2023 to 2033

Figure 23: North America Market Attractiveness Analysis by Country, 2023 to 2033

Figure 24: North America Market Share and BPS Analysis by Type, 2023 & 2033

Figure 25: North America Market Y-o-Y Growth Projections by Type, 2023 to 2033

Figure 26: North America Market Attractiveness Analysis by Type, 2023 to 2033

Figure 27: North America Market Share and BPS Analysis by Treatment, 2023 & 2033

Figure 28: North America Market Y-o-Y Growth Projections by Treatment, 2023 to 2033

Figure 29: North America Market Attractiveness Analysis by Treatment, 2023 to 2033

Figure 30: North America Market Share and BPS Analysis by End User, 2023 & 2033

Figure 31: North America Market Y-o-Y Growth Projections by End User, 2023 to 2033

Figure 32: North America Market Attractiveness Analysis by End User, 2023 to 2033

Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018 to 2022

Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033

Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018 to 2033

Figure 36: Latin America Market Incremental $ Opportunity, 2023 to 2033

Figure 37: Latin America Market Share Analysis by Country, 2023 & 2033

Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2023 to 2033

Figure 39: Latin America Market Attractiveness Analysis by Country, 2023 to 2033

Figure 40: Latin America Market Share and BPS Analysis by Type, 2023 & 2033

Figure 41: Latin America Market Y-o-Y Growth Projections by Type, 2023 to 2033

Figure 42: Latin America Market Attractiveness Analysis by Type, 2023 to 2033

Figure 43: Latin America Market Share and BPS Analysis by Treatment, 2023 & 2033

Figure 44: Latin America Market Y-o-Y Growth Projections by Treatment, 2023 to 2033

Figure 45: Latin America Market Attractiveness Analysis by Treatment, 2023 to 2033

Figure 46: Latin America Market Share and BPS Analysis by End User, 2023 & 2033

Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2023 to 2033

Figure 48: Latin America Market Attractiveness Analysis by End User, 2023 to 2033

Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018 to 2022

Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033

Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018 to 2033

Figure 52: Europe Market Incremental $ Opportunity, 2023 to 2033

Figure 53: Europe Market Share Analysis by Country, 2023 & 2033

Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2023 to 2033

Figure 55: Europe Market Attractiveness Analysis by Country, 2023 to 2033

Figure 56: Europe Market Share and BPS Analysis by Type, 2023 & 2033

Figure 57: Europe Market Y-o-Y Growth Projections by Type, 2023 to 2033

Figure 58: Europe Market Attractiveness Analysis by Type, 2023 to 2033

Figure 59: Europe Market Share and BPS Analysis by Treatment, 2023 & 2033

Figure 60: Europe Market Y-o-Y Growth Projections by Treatment, 2023 to 2033

Figure 61: Europe Market Attractiveness Analysis by Treatment, 2023 to 2033

Figure 62: Europe Market Share and BPS Analysis by End User, 2023 & 2033

Figure 63: Europe Market Y-o-Y Growth Projections by End User, 2023 to 2033

Figure 64: Europe Market Attractiveness Analysis by End User, 2023 to 2033

Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018 to 2022

Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033

Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018 to 2033

Figure 68: East Asia Market Incremental $ Opportunity, 2023 to 2033

Figure 69: East Asia Market Share Analysis by Country, 2023 & 2033

Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2023 to 2033

Figure 71: East Asia Market Attractiveness Analysis by Country, 2023 to 2033

Figure 72: East Asia Market Share and BPS Analysis by Type, 2023 & 2033

Figure 73: East Asia Market Y-o-Y Growth Projections by Type, 2023 to 2033

Figure 74: East Asia Market Attractiveness Analysis by Type, 2023 to 2033

Figure 75: East Asia Market Share and BPS Analysis by Treatment, 2023 & 2033

Figure 76: East Asia Market Y-o-Y Growth Projections by Treatment, 2023 to 2033

Figure 77: East Asia Market Attractiveness Analysis by Treatment, 2023 to 2033

Figure 78: East Asia Market Share and BPS Analysis by End User, 2023 & 2033

Figure 79: East Asia Market Y-o-Y Growth Projections by End User, 2023 to 2033

Figure 80: East Asia Market Attractiveness Analysis by End User, 2023 to 2033

Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018 to 2022

Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033

Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018 to 2033

Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2023 to 2033

Figure 85: South Asia & Oceania Market Share Analysis by Country, 2023 & 2033

Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2023 to 2033

Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2023 to 2033

Figure 88: South Asia & Oceania Market Share and BPS Analysis by Type, 2023 & 2033

Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Type, 2023 to 2033

Figure 90: South Asia & Oceania Market Attractiveness Analysis by Type, 2023 to 2033

Figure 91: South Asia & Oceania Market Share and BPS Analysis by Treatment, 2023 & 2033

Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Treatment, 2023 to 2033

Figure 93: South Asia & Oceania Market Attractiveness Analysis by Treatment, 2023 to 2033

Figure 94: South Asia & Oceania Market Share and BPS Analysis by End User, 2023 & 2033

Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2023 to 2033

Figure 96: South Asia & Oceania Market Attractiveness Analysis by End User, 2023 to 2033

Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018 to 2022

Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033

Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018 to 2033

Figure 100: MEA Market Incremental $ Opportunity, 2023 to 2033

Figure 101: MEA Market Share Analysis by Country, 2023 & 2033

Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2023 to 2033

Figure 103: MEA Market Attractiveness Analysis by Country, 2023 to 2033

Figure 104: MEA Market Share and BPS Analysis by Type, 2023 & 2033

Figure 105: MEA Market Y-o-Y Growth Projections by Type, 2023 to 2033

Figure 106: MEA Market Attractiveness Analysis by Type, 2023 to 2033

Figure 107: MEA Market Share and BPS Analysis by Treatment, 2023 & 2033

Figure 108: MEA Market Y-o-Y Growth Projections by Treatment, 2023 to 2033

Figure 109: MEA Market Attractiveness Analysis by Treatment, 2023 to 2033

Figure 110: MEA Market Share and BPS Analysis by End User, 2023 & 2033

Figure 111: MEA Market Y-o-Y Growth Projections by End User, 2023 to 2033

Figure 112: MEA Market Attractiveness Analysis by End User, 2023 to 2033

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

- FAQs -

What is the value of the hemianopsia market in 2023?

The global hemianopsia market is currently valued at US$ 333.9 million.

What is the projected market value for hemianopsia treatment products by 2033?

Sales of hemianopsia treatment solutions are expected to reach US$ 720.9 million by 2033.

At what rate is the hemianopsia market forecasted to expand during the forecast period?

Demand for hemianopsia treatment solutions is predicted to increase at a CAGR of 8% from 2023 to 2033.

Who are the leading market players in this space?

Vycor Medical, Inc., RetroSense Therapeutics, LLC, and Chadwick Optical are some of the leading companies in the market.

Which is the main factor driving the market for hemianopsia treatment solutions?

Increasing cases of brain injuries, stroke, and Alzheimer’s are driving market growth substantially.

Hemianopsia Market

Schedule a Call